Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach

国家艾滋病毒/艾滋病监测数据的风险因素重新分配:一种替代方法

阅读:1

Abstract

OBJECTIVE: The purpose of this study was to assess an alternative statistical approach-multiple imputation-to risk factor redistribution in the national human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) surveillance system as a way to adjust for missing risk factor information. METHODS: We used an approximate model incorporating random variation to impute values for missing risk factors for HIV and AIDS cases diagnosed from 2000 to 2004. The process was repeated M times to generate M datasets. We combined results from the datasets to compute an overall multiple imputation estimate and standard error (SE), and then compared results from multiple imputation and from risk factor redistribution. Variables in the imputation models were age at diagnosis, race/ethnicity, type of facility where diagnosis was made, region of residence, national origin, CD-4 T-lymphocyte cell count within six months of diagnosis, and reporting year. RESULTS: In HIV data, male-to-male sexual contact accounted for 67.3% of cases by risk factor redistribution and 70.4% (SE = 0.45) by multiple imputation. Also among males, injection drug use (IDU) accounted for 11.6% and 10.8% (SE = 0.34), and high-risk heterosexual contact for 15.1% and 13.0% (SE = 0.34) by risk factor redistribution and multiple imputation, respectively. Among females, IDU accounted for 18.2% and 17.9% (SE = 0.61), and high-risk heterosexual contact for 80.8% and 80.9% (SE = 0.63) by risk factor redistribution and multiple imputation, respectively. CONCLUSIONS: Because multiple imputation produces less biased subgroup estimates and offers objectivity and a semiautomated approach, we suggest consideration of its use in adjusting for missing risk factor information.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。